Once-daily dosing regimen for aminoglycoside plus β-Lactam combination therapy of serious bacterial infections: Comparative trial with netilmicin plus ceftriaxone

The American Journal of Medicine

Volumn 89, Issue 1, 1990, Pages 58-66

  ter Braak, Edith W ^a   de Vries, Peter J ^b   Bouter, K Paul ^b   van der Vegt, Sytze G ^a   Dorrestein, Gijsbert C ^a   Nortier, Johannes W ^b   van Dijk, Arie ^a   Verkooyen, Roel P ^b   Verbrugh, Henri A ^a,b  

^a Oudenrijn Ziekenuis   (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; NETILMICIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, COMBINED; BACTERIAL INFECTIONS; CEFTRIAXONE; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN; MALE; MIDDLE AGE; NETILMICIN; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T;

EID: 0025350747     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(90)90099-Y     Document Type: Article

References (40)

1. Challenging conventional aminoglycoside dosing regimens
2. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model
3. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia
4. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration
5. The postantibiotic effect
6. Kinetics of antimicrobial activity
7. Constant infusions versus intermittent doses of gentamicin against Pseudomonas aerugionasa in vitro
8. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin
9. First-exposure effect of netilmicin on bacterial susceptibility as a basis for modifying the dosage regimen of aminoglycoside antibiotics
10. The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity and antibacterial efficacy in a rat model of subcutaneous abscess
11. Choice of drug and dosage regimen
12. Aminoglycoside nephrotoxicity in dogs: dependence on drug, dose and regimen
13. Once daily dosing decreases renal accumulation of gentamicin and netilmicin
14. Renal and auditory tolerance of once daily dosing of netilmicin in healthy volunteers
15. Safety and efficacy of aminoglycosides once-a-day: experimental data and randomized, controlled evaluation in patients suffering from pelvic inflammatory disease
16. Ceftriaxone a review of its antibacterial activity pharmacological properties and therapeutic use
17. Prevention of aminoglycoside nephrotoxicity
18. APACHE—acute physiology and chronic health evaluation: a physiologically based classification system
19. APACHE II: a severity of disease classification system
20. Prescribing aids for gentamicin
21. Netilmicin pharmacokinetics after single intravenous doses to elderly male patients
22. Aminoglycoside monitoring: timing of peak levels is critical
23. Pharmacokinetics of netilmicin in the presence of normal or impaired renal function
24. Risk factors and comparisons of clinical nephrotoxicity and aminoglycosides
25. Controlled comparison of amikacin and gentamicin
26. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin
27. Algorithms for diagnosing infections used in the study on the efficacy of nosocomial infection control (SENIC Project)
28. Prediction of creatinine clearance from serum creatinine
29. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside
30. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin
31. Randomised controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin
32. A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections
33. Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections
34. Sample size nomograms for interpreting negative clinical studies
35. Netilmicin: Clinical pharmacokinetics and aspects on dosage schedules
36. Aminoglycoside toxicity
37. Antibiotics, DRGs, and the personal computer: simple techniques to estimate true cost
38. What is the cost of nephrotoxicity associated with aminoglycosides?